156 related articles for article (PubMed ID: 38834902)
1. Efficacy and Safety Evaluation of Tacrolimus-Eluting Stent in a Porcine Coronary Artery Model.
Park DS; Na MH; Jeong MH; Sim DS; Jin YJ; Kee HJ; Kim MK; Kim JH; Hong YJ; Cho KH; Hyun DY; Oh S; Lim KS; Byeon DH; Kim JH
Tissue Eng Regen Med; 2024 Jul; 21(5):723-735. PubMed ID: 38834902
[TBL] [Abstract][Full Text] [Related]
2. A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.
Ali MT; Martin K; Kumar AH; Cavallin E; Pierrou S; Gleeson BM; McPheat WL; Turner EC; Huang CL; Khider W; Vaughan C; Caplice NM
Biomaterials; 2015 Nov; 69():22-9. PubMed ID: 26275859
[TBL] [Abstract][Full Text] [Related]
3. Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery.
Zhu J; Zhang X; Niu J; Shi Y; Zhu Z; Dai D; Chen C; Pei J; Yuan G; Zhang R
Sci Rep; 2021 Apr; 11(1):7330. PubMed ID: 33795781
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
5. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
Sperling C; Waliszewski MW; Kherad B; Krackhardt F
Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
[TBL] [Abstract][Full Text] [Related]
6. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
[TBL] [Abstract][Full Text] [Related]
7. Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.
Carlyle WC; McClain JB; Tzafriri AR; Bailey L; Zani BG; Markham PM; Stanley JR; Edelman ER
J Control Release; 2012 Sep; 162(3):561-7. PubMed ID: 22800575
[TBL] [Abstract][Full Text] [Related]
8. Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model.
Park DS; Oh S; Jin YJ; Na MH; Kim M; Kim JH; Hyun DY; Cho KH; Hong YJ; Kim JH; Ahn Y; Hermida-Prieto M; Vázquez-Rodríguez JM; Gutiérrez-Chico JL; Mariñas-Pardo L; Lim KS; Park JK; Byeon DH; Cho YN; Kee SJ; Sim DS; Jeong MH
Tissue Eng Regen Med; 2024 Jan; 21(1):53-64. PubMed ID: 37973692
[TBL] [Abstract][Full Text] [Related]
9. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.
Chieffo A; Foglieni C; Nodari RL; Briguori C; Sangiorgi G; Latib A; Montorfano M; Airoldi F; Michev I; Carlino M; Colombo A; Maseri A
Am J Cardiol; 2009 Dec; 104(12):1660-7. PubMed ID: 19962471
[TBL] [Abstract][Full Text] [Related]
11. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model.
Hamada N; Miyata M; Eto H; Shirasawa T; Akasaki Y; Nagaki A; Tei C
Atherosclerosis; 2010 Jan; 208(1):97-103. PubMed ID: 19682688
[TBL] [Abstract][Full Text] [Related]
13. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
14. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
[TBL] [Abstract][Full Text] [Related]
15. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
Bedair TM; Kang SN; Joung YK; Han DK
J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury.
Chang SH; Lee CH; Yeh YH; Liu SJ; Wang CJ; Hsu MY; Chen WJ
Int J Nanomedicine; 2018; 13():1761-1771. PubMed ID: 29606869
[TBL] [Abstract][Full Text] [Related]
17. The neointimal response to stents eluting tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release.
van Beusekom H; Sorop O; Weymaere M; Duncker D; van der Giessen W
EuroIntervention; 2008 May; 4(1):139-47. PubMed ID: 19112791
[TBL] [Abstract][Full Text] [Related]
18. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
19. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
20. Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent.
Zhao Y; Du R; Zhou T; Yang D; Huang Y; Wang Y; Huang J; Ma X; He F; Qiu J; Wang G
Adv Healthc Mater; 2018 Aug; 7(15):e1800207. PubMed ID: 29770610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
